Pages that link to "Q34164683"
Jump to navigation
Jump to search
The following pages link to PI3K and mTOR signaling pathways in cancer: new data on targeted therapies (Q34164683):
Displaying 50 items.
- Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies (Q26774636) (← links)
- The La-Related Proteins, a Family with Connections to Cancer (Q26778934) (← links)
- Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design (Q27684223) (← links)
- RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors (Q27853211) (← links)
- Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death (Q28080874) (← links)
- Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma (Q28541805) (← links)
- PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia (Q30300538) (← links)
- Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma (Q33410761) (← links)
- EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas (Q33727426) (← links)
- HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90 cardiac myofibroblast activation (Q33891516) (← links)
- Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. (Q34177843) (← links)
- MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma (Q34182679) (← links)
- The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma (Q34309903) (← links)
- Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies (Q34571048) (← links)
- Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer (Q34663710) (← links)
- Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas (Q34669344) (← links)
- Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway (Q34718388) (← links)
- What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment (Q35135634) (← links)
- The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? (Q35680138) (← links)
- AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest (Q35975058) (← links)
- A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer (Q36010786) (← links)
- Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review (Q36070010) (← links)
- Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. (Q36198145) (← links)
- Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells. (Q36525180) (← links)
- p110δ PI3 kinase pathway: emerging roles in cancer (Q36647928) (← links)
- VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer (Q36656352) (← links)
- Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention (Q36678103) (← links)
- Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway (Q36741115) (← links)
- Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance (Q36815271) (← links)
- Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity. (Q36865078) (← links)
- Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors (Q36873574) (← links)
- Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers (Q36879470) (← links)
- Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers (Q36905878) (← links)
- Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma (Q36939981) (← links)
- Modulating roles of amiloride in irradiation-induced antiproliferative effects in glioblastoma multiforme cells involving Akt phosphorylation and the alternative splicing of apoptotic genes (Q37118693) (← links)
- Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells (Q37132224) (← links)
- PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma (Q37252398) (← links)
- PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. (Q37255490) (← links)
- Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma (Q37375027) (← links)
- The spatial structure of cell signaling systems (Q37408300) (← links)
- The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells. (Q37409754) (← links)
- The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells (Q37577442) (← links)
- Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population (Q37629003) (← links)
- Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest (Q37641562) (← links)
- Everolimus for the treatment of pancreatic neuroendocrine tumors (Q38032923) (← links)
- Inside out: targeting NHE1 as an intracellular and extracellular regulator of cancer progression (Q38068566) (← links)
- Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention (Q38070195) (← links)
- The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics (Q38092648) (← links)
- Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia (Q38113583) (← links)
- Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients (Q38187197) (← links)